Showing 1 - 2 results of 2 for search 'Wehkamp, J', query time: 0.02s Refine Results
  1. 1
    Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

    Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. by Hueber, W, Sands, B, Lewitzky, S, Vandemeulebroecke, M, Reinisch, W, Higgins, P, Wehkamp, J, Feagan, BG, Yao, MD, Karczewski, M, Karczewski, J, Pezous, N, Bek, S, Bruin, G, Mellgard, B, Berger, C, Londei, M, Bertolino, A, Tougas, G, Travis, S

    Published 2012
    Journal article
  2. 2
    Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: Unexpected results of a randomised, double-blindplacebo- controlled trial

    Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: Unexpected results of a randomised, double-blindplacebo- controlled trial by Hueber, W, Sands, B, Lewitzky, S, Vandemeulebroecke, M, Reinisch, W, Higgins, P, Wehkamp, J, Feagan, BG, Yao, MD, Karczewski, M, Karczewski, J, Pezous, N, Bek, S, Bruin, G, Mellgard, B, Berger, C, Londei, M, Bertolino, A, Tougas, G, Travis, S

    Published 2012
    Journal article

Search Tools: